Skip to content
healthcare.dev

MUCUS RELIEF DM

NDC 21130-997, Guaifenesin and Dextromethorphan HBr, tablet, extended release, from Better Living Brands LLC.

Product NDC
21130-997
Status
Listed
Labeler
Better Living Brands LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA206941
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/21130-997 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1
  • DEXTROMETHORPHAN HYDROBROMIDE30 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
21130-997-67211300997672 BLISTER PACK in 1 CARTON (21130-997-67) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 21130-997 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/21130-997 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 21130-997. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.